Equitable Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.81M | Buy |
5,643
+410
| +8% | +$244K | 0.16% | 106 |
|
|
2026
Q2 | $2.62M | Buy |
5,233
+2,643
| +102% | +$1.27M | 0.11% | 142 |
|
|
2026
Q1 | $1.27M | Sell |
2,590
-97
| -4% | -$52.6K | 0.06% | 201 |
|
|
2025
Q4 | $1.56M | Sell |
2,687
-2
| -0.1% | -$1.13K | 0.07% | 180 |
|
|
2025
Q3 | $1.3M | Sell |
2,689
-633
| -19% | -$295K | 0.06% | 201 |
|
|
2025
Q2 | $1.35M | Sell |
3,322
-114
| -3% | -$47.7K | 0.07% | 193 |
|
|
2025
Q1 | $1.71M | Sell |
3,436
-47
| -1% | -$25.5K | 0.09% | 164 |
|
|
2024
Q4 | $1.81M | Sell |
3,483
-100
| -3% | -$55K | 0.1% | 155 |
|
|
2024
Q3 | $2.22M | Sell |
3,583
-1,428
| -28% | -$845K | 0.14% | 137 |
|
|
2024
Q2 | $2.77M | Buy |
5,011
+322
| +7% | +$184K | 0.19% | 106 |
|
|
2024
Q1 | $2.73M | Buy |
4,689
+355
| +8% | +$199K | 0.19% | 108 |
|
|
2023
Q4 | $2.3M | Buy |
4,334
+751
| +21% | +$364K | 0.17% | 112 |
|
|
2023
Q3 | $1.81M | Sell |
3,583
-105
| -3% | -$56K | 0.15% | 119 |
|
|
2023
Q2 | $1.92M | Sell |
3,688
-1,668
| -31% | -$900K | 0.15% | 122 |
|
|
2023
Q1 | $3.09M | Sell |
5,356
-345
| -6% | -$194K | 0.24% | 79 |
|
|
2022
Q4 | $3.14M | Buy |
5,701
+3,135
| +122% | +$1.66M | 0.25% | 86 |
|
|
2022
Q3 | $1.3M | Hold |
2,566
| – | – | 0.11% | 150 |
|
|
2022
Q2 | $1.39M | Buy |
2,566
+20
| +0.8% | +$11K | 0.1% | 152 |
|
|
2022
Q1 | $1.5M | Hold |
2,546
| – | – | 0.1% | 149 |
|
|
2021
Q4 | $1.7M | Hold |
2,546
| – | – | 0.1% | 149 |
|
|
2021
Q3 | $1.46M | Sell |
2,546
-67
| -3% | -$36.8K | 0.09% | 152 |
|
|
2021
Q2 | $1.32M | Sell |
2,613
-6,118
| -70% | -$2.89M | 0.08% | 168 |
|
|
2021
Q1 | $3.98M | Buy |
8,731
+72
| +0.8% | +$34.4K | 0.3% | 93 |
|
|
2020
Q4 | $4.03M | Buy |
8,659
+3
| +0% | +$1.41K | 0.3% | 93 |
|
|
2020
Q3 | $3.82M | Sell |
8,656
-208
| -2% | -$85.9K | 0.33% | 79 |
|
|
2020
Q2 | $3.21M | Buy |
8,864
+607
| +7% | +$203K | 0.3% | 88 |
|
|
2020
Q1 | $2.34M | Sell |
8,257
-129
| -2% | -$40.7K | 0.26% | 102 |
|
|
2019
Q4 | $2.72M | Buy |
8,386
+95
| +1% | +$28.8K | 0.27% | 95 |
|
|
2019
Q3 | $2.42M | Buy |
8,291
+618
| +8% | +$177K | 0.25% | 97 |
|
|
2019
Q2 | $2.25M | Sell |
7,673
-107
| -1% | -$29.5K | 0.24% | 101 |
|
|
2019
Q1 | $2.13M | Sell |
7,780
-1,148
| -13% | -$286K | 0.25% | 97 |
|
|
2018
Q4 | $2M | Buy |
8,928
+403
| +5% | +$94.6K | 0.26% | 94 |
|
|
2018
Q3 | $2.08M | Buy |
8,525
+875
| +11% | +$201K | 0.24% | 105 |
|
|
2018
Q2 | $1.58M | Buy |
+7,650
| New | +$1.62M | 0.2% | 115 |
|
Other funds holding TMO
Equitable Trust's TMO Position: Q3 2026 in Review
Equitable Trust increased its Thermo Fisher Scientific (TMO) stake by 7.8% in Q3 2026, buying an estimated $244K and bringing the position to 5,643 shares worth $3.81M. The position accounts for 0.16% of the portfolio, ranked #106.
Equitable Trust first reported a position in TMO in Q2 2018 and has held it in 34 quarters since. The position peaked at $4.03M in Q4 2020. 507 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Equitable Trust held 5,643 shares of Thermo Fisher Scientific worth $3.81M as of Q3 2026.
- Equitable Trust bought 410 Thermo Fisher Scientific shares in Q3 2026, an estimated $244K.
- Thermo Fisher Scientific made up 0.16% of Equitable Trust's portfolio in Q3 2026, its #106 holding.
- Equitable Trust first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 34 quarters since.
- Equitable Trust's Thermo Fisher Scientific position peaked at $4.03M in Q4 2020.
- 507 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Equitable Trust's 13F filing for Q3 2026, filed 13 Oct 2026.